Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
The costly critical care provided by highly qualified personnel using state-of-the-art equipment in today
The Internet of Things (IoT) has been hailed by some commentators as one of the biggest revolutions in the hospital environment since the inception of patient monitoring equipment thirty years ago.
The latter triggered dramatic improvements in outcomes and explains the panoply of equipment now standard in every hospital room – from pulse oximeters, ECGs and apnea monitors to infusion pumps and ventilators.
False positives and negatives
Few doubt that healthcare today has improved because of such equipment. However, as the devices proliferated, another kind of risk has emerged. These monitoring devices operate independently, with no means to assimilate information from multiple sources and intelligently understand patient status. As a result, some devices can occasionally fail to issue an alarm (a false negative), while others do so wrongly (a false positive). On their part, healthcare staff members – whose numbers have shrunk as many of their tasks began to be handled by the devices – often tend to shut off what they believe are nuisance alarms.
Many are just that – nuisances. Some are not. In both cases of false positives and false negatives, human lives are often put at risk.
Nine of 10 healthcare IT departments ready for IoT
The Internet of Things (IoT) is seen to offer a way out of such challenges. IoT uses sensors, radio-frequency identification (RFID) and Real Time Location System (RTLS) to capture or monitor data and automatically trigger certain events.
In times past, healthcare sensors covered devices such as vital signs monitors. Today, those monitors and much other hospital equipment is connected by the IoT
A wave of new anesthetic agents on the market has been followed by intense interest in the cost-effectiveness of different anesthesia alternatives. This, however, is not something new.
Debate dates back 50 years
Attention to the economics of anesthesia use dates back a half century. In 1965, the
Respiratory tract infection (RTI) is the fourth leading cause of mortality globally resulting in around three million deaths per annum, predominantly from pneumonia. In the West, whilst RTIs do not wreak the same toll that they do in the lower income countries, they are the most frequent reason for consulting a general practitioner (GP). The majority of RTIs affect the upper respiratory tract and are of viral origin; numerous studies conclude that there is no benefit in prescribing antimicrobials for an acute uncomplicated RTI. And as currently one of the most serious global healthcare concerns is antimicrobial resistance (AMR), it is imperative that diagnosis and treatment at primary care level do not augment this problem. Relevant national guidelines exist in most European countries, but there are considerable variations across the EU in the frequency that antimicrobials are prescribed for patients with RTIs, ranging from 28% in the Netherlands to 92% in Greece.
Point-of-care testing by GPs, however, can allow more prudent use of antimicrobials. GPs are being encouraged to measure C reactive protein (CRP), a very early marker of inflammation produced by the liver, as an adjunct to clinical examination. Serum levels increase within six hours of infection, peak within two to three days and decline rapidly to baseline level once the infection is resolved. Bacterial infections result in high levels >100 mg/L, whereas levels in viral infections rarely exceed 50 mg/L. And a cost-effective CRP POC test that can be performed within five minutes is available. Although serum procalcitonin level is more specific for distinguishing between bacterial and viral infections, the POC tests for this analyte currently take longer to obtain a result and are thus more suitable for hospital settings. The consensus from European consortia concerned with managing RTI patients and combating antimicrobial resistance is that patients with CRP levels <20 mg/L should not be prescribed antimicrobials, those with levels >100 mg/L should, and for those with levels in between signs, symptoms and risk factors should all be scrutinized and antimicrobials prescribed if symptoms worsen. This approach appears to be acceptable to both patients and GPs.
Randomized clinical trials have been carried out in several countries comparing
With the launch of its new electronic health record (EHR) Portal, Agfa HealthCare is taking customers on a journey towards an integrated care solution. Easy to implement, yet providing a comprehensive road map, the EHR Portal integrates the experience and knowledge Agfa HealthCare has acquired in its long history, to drive towards the future of healthcare delivery with an architecture that can be extended into the entire care continuum. International Hospital talked to Joost Felix, Lead Product Manager, and J
April 2024
The medical devices information portal connecting healthcare professionals to global vendors
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
Accept settingsHide notification onlyCookie settingsWe may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.
Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.
We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.
We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.
.These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.
If you do not want us to track your visit to our site, you can disable this in your browser here:
.
We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page
Google Webfont Settings:
Google Maps Settings:
Google reCaptcha settings:
Vimeo and Youtube videos embedding:
.U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.
Privacy policy